Reboxetine as a potentially effective treatment for attention deficit hyperactivity disorder

J Child Adolesc Psychopharmacol. 2001 Summer;11(2):203-4. doi: 10.1089/104454601750284135.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic Uptake Inhibitors / therapeutic use*
  • Adult
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Humans
  • Male
  • Morpholines / therapeutic use*
  • Reboxetine

Substances

  • Adrenergic Uptake Inhibitors
  • Morpholines
  • Reboxetine